Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
. (2015) XVI International Workshop on Chronic Lymphocytic Leukemia 2015 6–9 September 2015 Sydney, Australia. Leukemia & Lymphoma 56:sup1, pages 1-166.
Read now
Read now
Martina Seiffert, Sascha Dietrich, Alexander Jethwa, Hanno Glimm, Peter Lichter & Thorsten Zenz. (2012) Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia. Leukemia & Lymphoma 53:6, pages 1023-1031.
Read now
Read now
Articles from other publishers (19)
Sara Bravo‐Navas, Lucrecia Yáñez, Íñigo Romón & And Carlos Pipaón. (2019)
Elevated
FANCA
expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function
. The FASEB Journal 33:9, pages 10477-10489.
Crossref
Crossref
L. Jeffrey Medeiros & Sergej N. Konoplev. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
505
559
.
Lukas P. Frenzel, H. Christian Reinhardt & Christian P. Pallasch. (2016) Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment. Oncology Research and Treatment 39:1-2, pages 9-16.
Crossref
Crossref
Patricia K. A. Mongini, Rashmi Gupta, Erin Boyle, Jennifer Nieto, Hyunjoo Lee, Joanna Stein, Jela Bandovic, Tatjana Stankovic, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Charles C. Chu & Nicholas Chiorazzi. (2015) TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells. The Journal of Immunology 195:3, pages 901-923.
Crossref
Crossref
Preetesh Jain, Michael Keating, Phillip A. Thompson, Long Trinh, Xuemei Wang, William Wierda, Alessandra Ferrajoli, Jan Burger, Hagop Kantarjian, Zeev Estrov, Lynne Abruzzo & Susan O'Brien. (2015) High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome. American Journal of Hematology 90:6, pages 471-477.
Crossref
Crossref
Susan Mahler Zneimer. 2014. Cytogenetic Abnormalities. Cytogenetic Abnormalities
423
428
.
Deniz Peker, Jianguo Tao & Ling Zhang. 2014. Molecular Pathology and Diagnostics of Cancer. Molecular Pathology and Diagnostics of Cancer
521
555
.
Oleg FedorchenkoMarius StiefelhagenAbdul A. Peer-ZadaRomy BarthelPetra MayerLaura EckeiAlexandra BreuerGiuliano CrispatzuNatascha RosenThomas LandwehrNils LilienthalMichael MöllmannManuel Montesinos-Rongen, Lukas Heukamp, Jan DürigMichael HallekGünter Fingerle-RowsonMarco Herling. (2013) CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia. Blood 121:20, pages 4126-4136.
Crossref
Crossref
Geothy Chakupurakal, Andrew Bell, Mike Griffiths, Farooq Wandroo & Paul Moss. (2012) Analysis of ZAP70 expression in adult acute lymphoblastic leukaemia by real time quantitative PCR. Molecular Cytogenetics 5:1, pages 22.
Crossref
Crossref
M. Fiegl, M. Erdel, I. Tinhofer, Y. Brychtova, A. Panovska, M. Doubek, K. Eigenberger, C. Fonatsch, G. Hopfinger, H. Mühlberger, A. Zabernigg, F. Falkner, G. Gastl, J. Mayer & R. Greil. (2010) Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Annals of Oncology 21:12, pages 2410-2419.
Crossref
Crossref
Michele Roullet & Adam Bagg. (2010) The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas. Advances in Anatomic Pathology 17:5, pages 333-358.
Crossref
Crossref
Shantaram S. Joshi, Amit K. Mittal, Peng Wang, Avadhut D. Joshi, Eileen Vu & Xioujun Wang. (2008) Differential gene expression in murine large cell B-cell lymphoma metastatic variants. International Immunopharmacology 8:9, pages 1257-1263.
Crossref
Crossref
Sandra Quijano, Antonio López, Ana Rasillo, José María Sayagués, Susana Barrena, Maria Luz Sánchez, Cristina Teodosio, Pilar Giraldo, Manuel Giralt, M. Carmen Pérez, Mercedes Romero, Luis Perdiguer & Alberto Orfao. (2007) Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B‐cells in chronic lymphocytic leukemia. Cytometry Part B: Clinical Cytometry 74B:3, pages 139-149.
Crossref
Crossref
Faramarz Naeim, P. Nagesh Rao & Wayne W. Grody. 2008. Hematopathology. Hematopathology
297
372
.
Kedar V. Inamdar & Carlos E. Bueso-Ramos. (2007) Pathology of chronic lymphocytic leukemia: an update. Annals of Diagnostic Pathology 11:5, pages 363-389.
Crossref
Crossref
Avadhut D. Joshi, Ganapati V. Hegde, John D. Dickinson, Amit K. Mittal, James C. Lynch, James D. Eudy, James O. Armitage, Philip J. Bierman, R. Gregory Bociek, Marcel P. Devetten, Julie M. Vose & Shantaram S. Joshi. (2007)
ATM, CTLA4, MNDA
, and
HEM1
in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia
. Clinical Cancer Research 13:18, pages 5295-5304.
Crossref
Crossref
Neil E. Kay & Tait D. Shanafelt. (2007) Prognostic factors in chronic lymphocytic leukemia. Current Hematologic Malignancy Reports 2:1, pages 49-55.
Crossref
Crossref
F.E. Cotter & R.L. Auer. (2007) Genetic alteration associated with chronic lymphocytic leukemia. Cytogenetic and Genome Research 118:2-4, pages 310-319.
Crossref
Crossref
Avadhut D. Joshi, John D. Dickinson, Ganapati V. Hegde, Warren G. Sanger, James O. Armitage, Philip J. Bierman, Robert G. Bociek, Marcel P. Devetten, Julie M. Vose & Shantaram S. Joshi. (2007) Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion. Cancer Genetics and Cytogenetics 172:2, pages 120-126.
Crossref
Crossref